These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37915901)

  • 1. Early aging and premature vascular aging in chronic kidney disease.
    Tanriover C; Copur S; Mutlu A; Peltek IB; Galassi A; Ciceri P; Cozzolino M; Kanbay M
    Clin Kidney J; 2023 Nov; 16(11):1751-1765. PubMed ID: 37915901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage.
    Dai L; Schurgers LJ; Shiels PG; Stenvinkel P
    Nephrol Dial Transplant; 2020 Mar; 35(Suppl 2):ii31-ii37. PubMed ID: 32162665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1.
    Yan J; Wang J; He JC; Zhong Y
    Front Endocrinol (Lausanne); 2022; 13():917773. PubMed ID: 35795148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.
    Bi X; Yang K; Zhang B; Zhao J
    Kidney Dis (Basel); 2020 Nov; 6(6):395-406. PubMed ID: 33313060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.
    Kaur R; Singh R
    Life Sci; 2022 Dec; 311(Pt B):121148. PubMed ID: 36336124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease.
    London GM
    Blood Purif; 2018; 45(1-3):154-158. PubMed ID: 29478047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of vascular calcification in CKD-evidence for premature ageing?
    Shanahan CM
    Nat Rev Nephrol; 2013 Nov; 9(11):661-70. PubMed ID: 24018414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients.
    Ebert T; Neytchev O; Witasp A; Kublickiene K; Stenvinkel P; Shiels PG
    Antioxid Redox Signal; 2021 Dec; 35(17):1426-1448. PubMed ID: 34006115
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
    Hutcheson JD; Goettsch C
    Circ Res; 2023 Apr; 132(8):993-1012. PubMed ID: 37053279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.
    Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE
    Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Basis and Pathogenesis of Skeletal Muscle Dysfunction as Cause of Frailty in Chronic Kidney Disease.
    Wesson DE; Mathur V; Tangri N
    Am J Nephrol; 2022; 53(10):740-752. PubMed ID: 36473450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway.
    Liu X; Chen A; Liang Q; Yang X; Dong Q; Fu M; Wang S; Li Y; Ye Y; Lan Z; Chen Y; Ou JS; Yang P; Lu L; Yan J
    Aging Cell; 2021 Jun; 20(6):e13377. PubMed ID: 33969611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.
    Chao CT; Lin SH
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of activin: the other side of chronic kidney disease-mineral bone disorder?
    Cianciolo G; La Manna G; Capelli I; Gasperoni L; Galassi A; Ciceri P; Cozzolino M
    Nephrol Dial Transplant; 2021 May; 36(6):966-974. PubMed ID: 32940690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and premature aging in advanced chronic kidney disease.
    Kooman JP; Dekker MJ; Usvyat LA; Kotanko P; van der Sande FM; Schalkwijk CG; Shiels PG; Stenvinkel P
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F938-F950. PubMed ID: 28701312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate and Klotho.
    Kuro-O M
    Kidney Int; 2011 Apr; 79121():S20-3. PubMed ID: 26746857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease.
    Dozio E; Caldiroli L; Molinari P; Castellano G; Delfrate NW; Romanelli MMC; Vettoretti S
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.